Works matching IS 14611457 AND DT 2022 AND VI 25 AND IP 4

Results: 8

Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel–Mediated Cardiotoxicity.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 280, doi. 10.1093/ijnp/pyab085

By:

Hackl, Benjamin;
Todt, Hannes;
Kubista, Helmut;
Hilber, Karlheinz;
Koenig, Xaver

Publication type:

Article

Mesenchymal Stem Cell–Derived Extracellular Vesicles Alleviate M1 Microglial Activation in Brain Injury of Mice With Subarachnoid Hemorrhage via microRNA-140-5p Delivery.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 328, doi. 10.1093/ijnp/pyab096

By:

Qian, Yu;
Li, Qiaoyu;
Chen, Lulu;
Sun, Jinyu;
Cao, Kan;
Mei, Zhaojun;
Lu, Xinyu

Publication type:

Article

Functional Reuniens and Rhomboid Nuclei Are Required for Proper Acquisition and Expression of Cued and Contextual Fear in Trace Fear Conditioning.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 319, doi. 10.1093/ijnp/pyab094

By:

Wu, Yi-ting;
Chang, Chun-hui

Publication type:

Article

Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 293, doi. 10.1093/ijnp/pyab092

By:

Abreu, Murilo S de;
Costa, Fabiano;
Giacomini, Ana C V V;
Demin, Konstantin A;
Zabegalov, Konstantin N;
Maslov, Gleb O;
Kositsyn, Yuriy M;
Petersen, Elena V;
Strekalova, Tatiana;
Rosemberg, Denis B;
Kalueff, Allan V

Publication type:

Article

Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 307, doi. 10.1093/ijnp/pyab089

By:

Flores-Burgess, Antonio;
Millón, Carmelo;
Gago, Belen;
García-Durán, Laura;
Cantero-García, Noelia;
Puigcerver, Araceli;
Narváez, José Angel;
Fuxe, Kjell;
Santín, Luis;
Díaz-Cabiale, Zaida

Publication type:

Article

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 283, doi. 10.1093/ijnp/pyab086

By:

Aldosary, Fahad;
Norris, Sandhaya;
Tremblay, Philippe;
James, Jonathan S;
Ritchie, James C;
Blier, Pierre

Publication type:

Article

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 269, doi. 10.1093/ijnp/pyab084

By:

Chen, Guang;
Chen, Li;
Zhang, Yun;
Li, Xiang;
Lane, Rosanne;
Lim, Pilar;
Daly, Ella J;
Furey, Maura L;
Fedgchin, Maggie;
Popova, Vanina;
Singh, Jaskaran B;
Drevets, Wayne C

Publication type:

Article

Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia.

Published in:

International Journal of Neuropsychopharmacology, 2022, v. 25, n. 4, p. 261, doi. 10.1093/ijnp/pyab073

By:

Torres-Bondia, Francisco;
Dakterzada, Farida;
Galván, Leonardo;
Buti, Miquel;
Besanson, Gaston;
Grill, Eric;
Buil, Roman;
Batlle, Jordi de;
Piñol-Ripoll, Gerard

Publication type:

Article